MedTrace Logo

Gastrointestinal Tolerability of a Partially Hydrolyzed Ready-to-feed Infant Formula in Healthy Newborns

NCT05097924 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2022-07-06

No results posted yet for this study

Summary

Gastrointestinal tolerability of a partially hydrolyzed, whey-based, ready-to-feed infant formula in healthy newborns during the birth hospitalization period: a post-market study

Conditions

  • Infant Nutritional Physiological Phenomena
  • Infant Formula

Interventions

OTHER

NAN Supreme HypoAllergenic Starter Infant Formula in ready-to-feed format

Post-market observational study with formula feeding administered via standard of care

Sponsors & Collaborators

  • Société des Produits Nestlé (SPN)

    lead INDUSTRY

Eligibility

Min Age
0 Months
Max Age
24 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-02-01
Primary Completion
2022-03-09
Completion
2022-03-09

Countries

  • Saudi Arabia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05097924 on ClinicalTrials.gov